首页> 外文期刊>Nature protocols erecipes for researchers >Near-IR photoactivation using mesoporous silica-coated NaYF4:Yb,Er/Tm upconversion nanoparticles
【24h】

Near-IR photoactivation using mesoporous silica-coated NaYF4:Yb,Er/Tm upconversion nanoparticles

机译:使用介孔二氧化硅包覆的NaYF4:Yb,Er / Tm上转换纳米粒子的近红外光活化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Photoactivation is a process in which light is used to 'activate' photolabile therapeutics. As a therapeutic strategy, its advantages are that it is noninvasive and that a high degree of spatial and temporal control is possible. However, conventional photoactivation techniques are hampered by the limited penetration depth of the UV and visible lights to which the photosensitive compounds are responsive. Here we describe a protocol for the use of upconversion nanoparticles (UCNs) as light transducers to convert deeply penetrating near-infrared (NIR) light to UV-visible wavelengths matching that of the absorption spectrum of photosensitive therapeutics. This allows the use of deep-penetrating and biologically friendly NIR light instead of low-penetrating and/or toxic visible or UV lights for photoactivation. In this protocol, we focus on two photoactivation applications: photodynamic therapy (PDT) and photoactivated control of gene expression. We describe how to prepare and characterize the UCNs, as well as how to check their function in biochemical assays and in cells. For both applications, the UCNs are coated with mesoporous silica for easy loading of the therapeutics. For PDT, the UCNs are coated with polyethylene glycol (PEG) for stabilization and folic acid for tumor targeting and then loaded with photosensitizers that would be expected to kill cells by singlet oxygen production; the nanoparticles are injected intravenously. For photoactivated control of gene expression, knockdown of essential tumor genes is achieved using UCNs loaded with caged nucleic acids, which are injected intratumorally. The whole process from nanoparticle synthesis to animal studies takes similar to 36 d.
机译:光活化是其中光用于“活化”光不稳定疗法的过程。作为一种治疗策略,其优点是它是非侵入性的,并且高度的空间和时间控制是可能的。然而,常规的光活化技术受到光敏化合物响应的UV和可见光的有限穿透深度的阻碍。在这里,我们描述了使用上转换纳米颗粒(UCNs)作为光传感器将深穿透的近红外(NIR)光转换为与光敏疗法的吸收光谱相匹配的UV可见波长的协议。这允许使用深穿透和生物友好的近红外光,而不是低穿透和/或有毒的可见光或紫外光进行光活化。在此协议中,我们专注于两个光激活应用程序:光动力疗法(PDT)和基因表达的光激活控制。我们描述了如何准备和表征UCN,以及如何在生化分析和细胞中检查其功能。对于这两种应用,UCN均涂有中孔二氧化硅,以方便装载治疗剂。对于PDT,UCN涂有聚乙二醇(PEG)进行稳定处理,叶酸进行肿瘤靶向,然后装载光敏剂,这些光敏剂有望通过产生单线态氧来杀死细胞。纳米颗粒被静脉内注射。为了光活化控制基因表达,使用装载有笼内核酸的UCN来实现必需肿瘤基因的敲低,该笼内核酸被瘤内注射。从纳米颗粒合成到动物研究的整个过程耗时约36 d。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号